ADAMS ERIC A (CEO & President) purchased 1763.5% of their position (41.60K shares) of INMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $14.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/21/2024ACC: 0001213900-24-015703
DirectorOfficer10% Owner· CEO & President
Since Nov 2020
+41.60K
Net shares
Net buyer
$14.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
41.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+41.60K
Price / share
$0.36
Trade value
$14.92K
% of position
1763.5%
2/20/2024
2.36K→43.96K
Total
Net shares
+41.60K
Net value
$14.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2024 | P · Purchase | +41.60K | $0.36 | $14.92K | 1763.5% | 2.36K | 43.96K |
| Total | +41.60K | $14.92K | ||||||
Derivative Transactions0
No derivative transactions reported